BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12370621)

  • 1. Breast cancer prevention and surveillance.
    Hindle WH
    Clin Obstet Gynecol; 2002 Sep; 45(3):778-83. PubMed ID: 12370621
    [No Abstract]   [Full Text] [Related]  

  • 2. Breast cancer prevention.
    Rodabaugh KJ; Bloss JD
    Clin Obstet Gynecol; 2001 Sep; 44(3):478-84. PubMed ID: 11685873
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective estrogen receptor modulators and prevention of invasive breast cancer.
    Gradishar WJ; Cella D
    JAMA; 2006 Jun; 295(23):2784-6. PubMed ID: 16754726
    [No Abstract]   [Full Text] [Related]  

  • 4. Primary prevention of breast cancer: new approaches.
    Cummings SR
    Maturitas; 2007 May; 57(1):39-41. PubMed ID: 17391879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug prevention and proper nutrition. Prevention of breast cancer as in coronary heart disease?].
    Aumiller J
    MMW Fortschr Med; 2007 Feb; 149(7):18-9. PubMed ID: 17612226
    [No Abstract]   [Full Text] [Related]  

  • 6. Selective oestrogen receptor modulation: molecular pharmacology for the millennium.
    Levenson AS; Jordan VC
    Eur J Cancer; 1999 Dec; 35(14):1974-85. PubMed ID: 10711240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raloxifene vs tamoxifen.
    Goldstein SR
    JAMA; 2007 Jan; 297(3):263-4; author reply 264. PubMed ID: 17227974
    [No Abstract]   [Full Text] [Related]  

  • 8. Tamoxifen prevention of breast cancer: an instance of the fingerpost.
    Lippman SM; Brown PH
    J Natl Cancer Inst; 1999 Nov; 91(21):1809-19. PubMed ID: 10547388
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of selective estrogen receptor modulators in the prevention of breast cancer: comparison of the clinical trials.
    Martino S; Costantino J; McNabb M; Mershon J; Bryant K; Powles T; Secrest RJ
    Oncologist; 2004; 9(2):116-25. PubMed ID: 15047916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The selective estrogen receptor modulators in breast cancer prevention.
    Li F; Dou J; Wei L; Li S; Liu J
    Cancer Chemother Pharmacol; 2016 May; 77(5):895-903. PubMed ID: 26787504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention of breast cancer.
    Zelnak AB; O'Regan RM
    Curr Probl Cancer; 2004; 28(4):201-17. PubMed ID: 15318323
    [No Abstract]   [Full Text] [Related]  

  • 12. Update in general internal medicine.
    Mincey BA
    Ann Intern Med; 2001 Aug; 135(4):300-1. PubMed ID: 11511149
    [No Abstract]   [Full Text] [Related]  

  • 13. Breast cancer chemoprevention: A service in need of menopause specialist support.
    Marsden J
    Post Reprod Health; 2017 Mar; 23(1):15-21. PubMed ID: 28081658
    [No Abstract]   [Full Text] [Related]  

  • 14. Breast cancer chemoprevention: current status and future directions.
    Wickerham DL; Tan-Chiu E
    Semin Oncol; 2001 Jun; 28(3):253-9. PubMed ID: 11402435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.
    Vogel VG; Costantino JP; Wickerham DL; Cronin WM; Cecchini RS; Atkins JN; Bevers TB; Fehrenbacher L; Pajon ER; Wade JL; Robidoux A; Margolese RG; James J; Lippman SM; Runowicz CD; Ganz PA; Reis SE; McCaskill-Stevens W; Ford LG; Jordan VC; Wolmark N;
    JAMA; 2006 Jun; 295(23):2727-41. PubMed ID: 16754727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer chemoprevention: a review of selective estrogen receptor modulators.
    Johansen AM
    Clin J Oncol Nurs; 2005 Jun; 9(3):317-20. PubMed ID: 15973842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of antiestrogens and aromatase inhibitors in breast cancer treatment.
    Bentrem DJ; Jordan VC
    Curr Opin Obstet Gynecol; 2002 Feb; 14(1):5-12. PubMed ID: 11801870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on breast cancer prevention trials.
    Wickerham DL; Fourchotte V
    Int J Gynecol Cancer; 2006; 16 Suppl 2():498-501. PubMed ID: 17010056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of SERMs on breast tissue.
    Goldstein SR
    J Endocrinol Invest; 1999 Sep; 22(8):636-40. PubMed ID: 10532251
    [No Abstract]   [Full Text] [Related]  

  • 20. STAR: first-year recruitment efforts set brisk pace for future.
    CA Cancer J Clin; 2000; 50(5):271-2. PubMed ID: 11075236
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.